Live Breaking News & Updates on Countries Clinical Trial Partnership

Stay updated with breaking news from Countries clinical trial partnership. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Nigeria, others to begin Lassa fever vaccine clinical trials


Nigeria, others to begin Lassa fever vaccine clinical trials
The Punch
Published 29 June 2021
The United States of America has said that a new phase of Lassa fever vaccine clinical trials is set to begin in Nigeria, Liberia and Sierra Leone.
This was disclosed in a statement on Monday by the Public Affairs Unit of the United States Diplomatic Mission to Nigeria.
According to the statement, the International AIDS Vaccine Initiative was awarded €22.8m by the European and Developing Countries Clinical Trial Partnership and the Coalition for Epidemic Preparedness Innovations to conduct a Phase IIB trial of the IAVI Lassa fever vaccine candidate among adults and children in Nigeria, Liberia and Sierra Leone. ....

United States , Sierra Leone , Walter Reed Army Institute Of Research , Clinical Research Centre , Vaccine Initiative , Countries Clinical Trial Partnership , Coalition For Epidemic Preparedness Innovations , Public Affairs Unit , United States Diplomatic Mission , Developing Countries Clinical Trial Partnership , Epidemic Preparedness Innovations , North America , Lassa Fever Vaccine Efficacy , West Africa , Walter Reed Army Institute , ஒன்றுபட்டது மாநிலங்களில் , சியரா லியோன் , வால்டர் நாணல் இராணுவம் நிறுவனம் ஆஃப் ஆராய்ச்சி , மருத்துவ ஆராய்ச்சி மையம் , தடுப்பூசி முயற்சி , நாடுகள் மருத்துவ சோதனை கூட்டு , கூட்டணி க்கு பெருவாரியாக பரவும் தொற்று நோய் ப்ரிப்யாரெட்நெஸ் புதுமைகள் , பொது வாழ்க்கைத்தொழில்கள் அலகு , ஒன்றுபட்டது மாநிலங்களில் இராஜதந்திர பணி , வளரும் நாடுகள் மருத்துவ சோதனை கூட்டு , பெருவாரியாக பரவும் தொற்று நோய் ப்ரிப்யாரெட்நெஸ் புதுமைகள் ,

In South Africa, COVID-19 Pits Traditional Medicine Against Clinical Trial Rules


In South Africa, COVID-19 Pits Traditional Medicine Against Clinical Trial Rules
31/12/2020
In June,
Artemisia afra was in high demand on the streets of Johannesburg in South Africa. To treat COVID-19 symptoms, the Indigenous herb’s silvery leaves were for sale at roadside vendors and in the city’s popular traditional markets. Some people even pulled the plant from private gardens. And on the sides of nearby highways, people held signs for “mhlonyane” (
A. afra’s isiZulu name) and offered bushels to passing motorists like bouquets. Between February and July, the herb doubled in price.
People in the region have consumed the bitter plant for centuries to treat illnesses from colds to intestinal worms. With deaths rising as South Africa battled its first COVID-19 wave, people have turned to ....

South Africa , Kwazulu Natal , University Of Cape Town , Western Cape , South Africans , South African , Ossy Kasilo , Motlalepula Matsabisa , Francois Venter , Salim Abdool Karim , Phephisile Maseko , Vinesh Maharaj , Nceba Gqaleni , Yuven Gounden , Hlupheka Chabalala , Kelly Chibale , Andry Rajoelina , Africa Medicines Control Council , Africa Centre For Disease , Wits Reproductive Health , Research Team , African Health Products Regulatory Authority Sahpra , Traditional Healer Organisation , Stellenbosch University , Africa Ministerial Advisory Committee , Africa Council For Scientific ,